{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:17:58Z","timestamp":1793830678904,"version":"4.6.1"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-025-04535-8","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T15:51:46Z","timestamp":1754409106000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["From signaling pathways to clinical trials: mesenchymal stem cells as multimodal regenerative architects in liver cirrhosis therapy"],"prefix":"10.1186","volume":"16","author":[{"given":"Vida","family":"Bozorgi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahnaz","family":"Babaahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Salehi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamshid","family":"Vafaeimanesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4933-5250","authenticated-orcid":false,"given":"Ensiyeh","family":"Hajizadeh-Saffar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,5]]},"reference":[{"key":"4535_CR1","unstructured":"Sharma B, John S. Hepatic cirrhosis. 2018."},{"issue":"1","key":"4535_CR2","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","volume":"70","author":"SK Asrani","year":"2019","unstructured":"Asrani SK, Devarbhavi H, Eaton J, Kamath PS. Burden of liver diseases in the world. J Hepatol. 2019;70(1):151\u201371.","journal-title":"J Hepatol"},{"issue":"10308","key":"4535_CR3","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","volume":"398","author":"P Gin\u00e8s","year":"2021","unstructured":"Gin\u00e8s P, Krag A, Abraldes JG, Sol\u00e0 E, Fabrellas N, Kamath PS. Liver cirrhosis. Lancet. 2021;398(10308):1359\u201376.","journal-title":"Lancet"},{"issue":"8","key":"4535_CR4","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/S2468-1253(22)00050-4","volume":"7","author":"CJ Alberts","year":"2022","unstructured":"Alberts CJ, Clifford GM, Georges D, Negro F, Lesi OA, Hutin YJ, et al. Worldwide prevalence of hepatitis B virus and hepatitis C virus among patients with cirrhosis at country, region, and global levels: a systematic review. Lancet Gastroenterol Hepatol. 2022;7(8):724\u201335.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"3","key":"4535_CR5","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/S0168-8278(02)00420-8","volume":"38","author":"M Merli","year":"2003","unstructured":"Merli M, Nicolini G, Angeloni S, Rinaldi V, De Santis A, Merkel C, et al. Incidence and natural history of small esophageal varices in cirrhotic patients. J Hepatol. 2003;38(3):266\u201372.","journal-title":"J Hepatol"},{"issue":"18","key":"4535_CR6","doi-asserted-by":"publisher","first-page":"5442","DOI":"10.3748\/wjg.v20.i18.5442","volume":"20","author":"S Nusrat","year":"2014","unstructured":"Nusrat S, Khan MS, Fazili J, Madhoun MF. Cirrhosis and its complications: evidence based treatment. World J Gastroenterology: WJG. 2014;20(18):5442.","journal-title":"World J Gastroenterology: WJG"},{"issue":"9","key":"4535_CR7","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1111\/apt.12044","volume":"36","author":"AA Sohrabpour","year":"2012","unstructured":"Sohrabpour AA, Mohamadnejad M, Malekzadeh R. The reversibility of cirrhosis. Aliment Pharmacol Ther. 2012;36(9):824\u201332.","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"4535_CR8","doi-asserted-by":"publisher","first-page":"875","DOI":"10.3390\/cells9040875","volume":"9","author":"N Roehlen","year":"2020","unstructured":"Roehlen N, Crouchet E, Baumert TF. Liver fibrosis: mechanistic concepts and therapeutic perspectives. Cells. 2020;9(4):875.","journal-title":"Cells"},{"issue":"18","key":"4535_CR9","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1001\/jama.2023.5997","volume":"329","author":"EB Tapper","year":"2023","unstructured":"Tapper EB, Parikh ND. Diagnosis and management of cirrhosis and its complications: a review. JAMA. 2023;329(18):1589\u2013602.","journal-title":"JAMA"},{"issue":"2","key":"4535_CR10","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s12072-023-10629-3","volume":"18","author":"D-S Kim","year":"2024","unstructured":"Kim D-S, Yoon Y-I, Kim BK, Choudhury A, Kulkarni A, Park JY, et al. Asian Pacific association for the study of the liver clinical practice guidelines on liver transplantation. Hep Intl. 2024;18(2):299\u2013383.","journal-title":"Hep Intl"},{"issue":"17","key":"4535_CR11","doi-asserted-by":"publisher","first-page":"5586","DOI":"10.3390\/jcm12175586","volume":"12","author":"A Khalil","year":"2023","unstructured":"Khalil A, Quaglia A, G\u00e9lat P, Saffari N, Rashidi H, Davidson B. New developments and challenges in liver transplantation. J Clin Med. 2023;12(17):5586.","journal-title":"J Clin Med"},{"issue":"5","key":"4535_CR12","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.jhep.2019.06.030","volume":"71","author":"SJ Mun","year":"2019","unstructured":"Mun SJ, Ryu J-S, Lee M-O, Son YS, Oh SJ, Cho H-S, et al. Generation of expandable human pluripotent stem cell-derived hepatocyte-like liver organoids. J Hepatol. 2019;71(5):970\u201385.","journal-title":"J Hepatol"},{"issue":"6","key":"4535_CR13","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1016\/j.cell.2018.11.012","volume":"175","author":"WC Peng","year":"2018","unstructured":"Peng WC, Logan CY, Fish M, Anbarchian T, Aguisanda F, \u00c1lvarez-Varela A, et al. Inflammatory cytokine TNF\u03b1 promotes the long-term expansion of primary hepatocytes in 3D culture. Cell. 2018;175(6):1607\u201319. e15.","journal-title":"Cell"},{"issue":"8","key":"4535_CR14","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1016\/j.stemcr.2023.06.005","volume":"18","author":"V Cardinale","year":"2023","unstructured":"Cardinale V, Lanthier N, Baptista PM, Carpino G, Carnevale G, Orlando G, et al. Cell transplantation-based regenerative medicine in liver diseases. Stem Cell Rep. 2023;18(8):1555\u201372.","journal-title":"Stem Cell Rep"},{"issue":"6","key":"4535_CR15","doi-asserted-by":"publisher","first-page":"657","DOI":"10.3109\/14653249.2012.663526","volume":"14","author":"M Joshi","year":"2012","unstructured":"Joshi M, Patil B, He P, Holgersson Z, Olausson J, Sumitran-Holgersson M. Fetal liver-derived mesenchymal stromal cells augment engraftment of transplanted hepatocytes. Cytotherapy. 2012;14(6):657\u201369.","journal-title":"Cytotherapy"},{"issue":"9","key":"4535_CR16","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.4252\/wjsc.v13.i9.1349","volume":"13","author":"M-C Wu","year":"2021","unstructured":"Wu M-C, Meng Q-H. Current Understanding of mesenchymal stem cells in liver diseases. World J Stem Cells. 2021;13(9):1349.","journal-title":"World J Stem Cells"},{"issue":"2","key":"4535_CR17","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3390\/biomedicines11020445","volume":"11","author":"A Kulesza","year":"2023","unstructured":"Kulesza A, Paczek L, Burdzinska A. The role of COX-2 and PGE2 in the regulation of Immunomodulation and other functions of mesenchymal stromal cells. Biomedicines. 2023;11(2):445.","journal-title":"Biomedicines"},{"issue":"9","key":"4535_CR18","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.3727\/096368913X667709","volume":"23","author":"X Liang","year":"2014","unstructured":"Liang X, Ding Y, Zhang Y, Tse H-F, Lian Q. Paracrine mechanisms of mesenchymal stem cell-based therapy: current status and perspectives. Cell Transplant. 2014;23(9):1045\u201359.","journal-title":"Cell Transplant"},{"issue":"12","key":"4535_CR19","doi-asserted-by":"publisher","first-page":"7314","DOI":"10.1021\/acsbiomaterials.4c01279","volume":"10","author":"QT Ehlen","year":"2024","unstructured":"Ehlen QT, Costello JP, Mirsky NA, Slavin BV, Parra M, Ptashnik A, et al. Treatment of bone defects and nonunion via novel delivery mechanisms, growth factors, and stem cells: A review. ACS Biomaterials Sci Eng. 2024;10(12):7314\u201336.","journal-title":"ACS Biomaterials Sci Eng"},{"issue":"12","key":"4535_CR20","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1089\/scd.2011.0674","volume":"21","author":"ST-F Hsiao","year":"2012","unstructured":"Hsiao ST-F, Asgari A, Lokmic Z, Sinclair R, Dusting GJ, Lim SY, et al. Comparative analysis of paracrine factor expression in human adult mesenchymal stem cells derived from bone marrow, adipose, and dermal tissue. Stem Cells Dev. 2012;21(12):2189\u2013203.","journal-title":"Stem Cells Dev"},{"issue":"11","key":"4535_CR21","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1136\/bjophthalmol-2016-310012","volume":"101","author":"Z Jiang","year":"2017","unstructured":"Jiang Z, Liu G, Meng F, Wang W, Hao P, Xiang Y, et al. Paracrine effects of mesenchymal stem cells on the activation of keratocytes. Br J Ophthalmol. 2017;101(11):1583\u201390.","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"4535_CR22","first-page":"831","volume":"6","author":"A Xagorari","year":"2013","unstructured":"Xagorari A, Siotou E, Yiangou M, Tsolaki E, Bougiouklis D, Sakkas L, et al. Protective effect of mesenchymal stem cell-conditioned medium on hepatic cell apoptosis after acute liver injury. Int J Clin Exp Pathol. 2013;6(5):831.","journal-title":"Int J Clin Exp Pathol"},{"key":"4535_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-016-0792-1","volume":"14","author":"B Huang","year":"2016","unstructured":"Huang B, Cheng X, Wang H, Huang W, la Ga Hu Z, Wang D, et al. Mesenchymal stem cells and their secreted molecules predominantly ameliorate fulminant hepatic failure and chronic liver fibrosis in mice respectively. J Translational Med. 2016;14:1\u201312.","journal-title":"J Translational Med"},{"issue":"1","key":"4535_CR24","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.stem.2009.05.003","volume":"5","author":"RH Lee","year":"2009","unstructured":"Lee RH, Pulin AA, Seo MJ, Kota DJ, Ylostalo J, Larson BL, et al. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell. 2009;5(1):54\u201363.","journal-title":"Cell Stem Cell"},{"issue":"3","key":"4535_CR25","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1002\/hep.25722","volume":"56","author":"J Li","year":"2012","unstructured":"Li J, Zhang L, Xin J, Jiang L, Li J, Zhang T, et al. Immediate intraportal transplantation of human bone marrow mesenchymal stem cells prevents death from fulminant hepatic failure in pigs. Hepatology. 2012;56(3):1044\u201352.","journal-title":"Hepatology"},{"key":"4535_CR26","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/jgh.12029","volume":"28","author":"L Wang","year":"2013","unstructured":"Wang L, Li J, Liu H, Li Y, Fu J, Sun Y, et al. A pilot study of umbilical cord-derived mesenchymal stem cell transfusion in patients with primary biliary cirrhosis. J Gastroenterol Hepatol. 2013;28:85\u201392.","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"4535_CR27","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/jcmm.12482","volume":"19","author":"S Liu Wh","year":"2015","unstructured":"Liu Wh S, Fq R, Ln G, Wq, Wang T, Feng Yx, et al. The multiple functional roles of mesenchymal stem cells in participating in treating liver diseases. J Cell Mol Med. 2015;19(3):511\u201320.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"4535_CR28","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/hep.29189","volume":"66","author":"C Lin Bl","year":"2017","unstructured":"Lin Bl C, Jf Q, Wh W, Kw X, Dy C, Xy, et al. Allogeneic bone marrow\u2013derived mesenchymal stromal cells for hepatitis B virus\u2013related acute-on\u2010chronic liver failure: a randomized controlled trial. Hepatology. 2017;66(1):209\u201319.","journal-title":"Hepatology"},{"issue":"6","key":"4535_CR29","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1002\/hep.28693","volume":"64","author":"KT Suk","year":"2016","unstructured":"Suk KT, Yoon JH, Kim MY, Kim CW, Kim JK, Park H, et al. Transplantation with autologous bone marrow-derived mesenchymal stem cells for alcoholic cirrhosis: phase 2 trial. Hepatology. 2016;64(6):2185\u201397.","journal-title":"Hepatology"},{"issue":"9","key":"4535_CR30","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1111\/1756-185X.13015","volume":"20","author":"J Liang","year":"2017","unstructured":"Liang J, Zhang H, Zhao C, Wang D, Ma X, Zhao S, et al. Effects of allogeneic mesenchymal stem cell transplantation in the treatment of liver cirrhosis caused by autoimmune diseases. Int J Rheum Dis. 2017;20(9):1219\u201326.","journal-title":"Int J Rheum Dis"},{"issue":"1","key":"4535_CR31","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13287-024-04127-y","volume":"16","author":"W-C Huang","year":"2025","unstructured":"Huang W-C, Li Y-C, Chen P-X, Ma KS-K, Wang L-T. Mesenchymal stem cell therapy as a game-changer in liver diseases: review of current clinical trials. Stem Cell Res Ther. 2025;16(1):3.","journal-title":"Stem Cell Res Ther"},{"issue":"4","key":"4535_CR32","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3390\/livers2040023","volume":"2","author":"L de la Conde","year":"2022","unstructured":"de la Conde L, Goicoechea L, Torres S, Garcia-Ruiz C, Fernandez-Checa JC. Role of oxidative stress in liver disorders. Livers. 2022;2(4):283\u2013314.","journal-title":"Livers"},{"issue":"10","key":"4535_CR33","doi-asserted-by":"publisher","first-page":"3104","DOI":"10.3390\/ijms19103104","volume":"19","author":"S Mihm","year":"2018","unstructured":"Mihm S. Danger-associated molecular patterns (DAMPs): molecular triggers for sterile inflammation in the liver. Int J Mol Sci. 2018;19(10):3104.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"4535_CR34","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.3724\/abbs.2022137","volume":"54","author":"Y Guan","year":"2022","unstructured":"Guan Y, Gu Y, Li H, Liang B, Han C, Zhang Y, et al. NLRP3 inflammasome activation mechanism and its role in autoimmune liver disease: role of NLRP3 inflammasome in autoimmune liver disease. Acta Biochim Biophys Sin. 2022;54(11):1577.","journal-title":"Acta Biochim Biophys Sin"},{"issue":"1","key":"4535_CR35","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1172\/JCI93558","volume":"128","author":"SE Di Carlo","year":"2018","unstructured":"Di Carlo SE, Peduto L. The perivascular origin of pathological fibroblasts. J Clin Investig. 2018;128(1):54\u201363.","journal-title":"J Clin Investig"},{"issue":"4","key":"4535_CR36","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1002\/j.2040-4603.2013.tb00529.x","volume":"3","author":"JE Puche","year":"2013","unstructured":"Puche JE, Saiman Y, Friedman SL. Hepatic stellate cells and liver fibrosis. Compr Physiol. 2013;3(4):1473\u201392.","journal-title":"Compr Physiol"},{"issue":"1","key":"4535_CR37","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1186\/s13287-020-01855-9","volume":"11","author":"X Wu","year":"2020","unstructured":"Wu X, Jiang J, Gu Z, Zhang J, Chen Y, Liu X. Mesenchymal stromal cell therapies: Immunomodulatory properties and clinical progress. Stem Cell Res Ther. 2020;11(1):345.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"4535_CR38","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.arcmed.2020.08.006","volume":"52","author":"DE Rodr\u00edguez-Fuentes","year":"2021","unstructured":"Rodr\u00edguez-Fuentes DE, Fern\u00e1ndez-Garza LE, Samia-Meza JA, Barrera-Barrera SA, Caplan AI, Barrera-Salda\u00f1a HA. Mesenchymal stem cells current clinical applications: a systematic review. Arch Med Res. 2021;52(1):93\u2013101.","journal-title":"Arch Med Res"},{"issue":"5","key":"4535_CR39","doi-asserted-by":"publisher","first-page":"580","DOI":"10.3904\/kjim.2015.30.5.580","volume":"30","author":"YW Eom","year":"2015","unstructured":"Eom YW, Shim KY, Baik SK. Mesenchymal stem cell therapy for liver fibrosis. Korean J Intern Med. 2015;30(5):580.","journal-title":"Korean J Intern Med"},{"key":"4535_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-020-01895-1","volume":"11","author":"C Hu","year":"2020","unstructured":"Hu C, Zhao L, Zhang L, Bao Q, Li L. Mesenchymal stem cell-based cell-free strategies: safe and effective treatments for liver injury. Stem Cell Res Ther. 2020;11:1\u201312.","journal-title":"Stem Cell Res Ther"},{"issue":"11","key":"4535_CR41","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/ni.3002","volume":"15","author":"Y Wang","year":"2014","unstructured":"Wang Y, Chen X, Cao W, Shi Y. Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications. Nat Immunol. 2014;15(11):1009\u201316.","journal-title":"Nat Immunol"},{"issue":"10","key":"4535_CR42","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1016\/j.stem.2021.09.001","volume":"28","author":"H Soliman","year":"2021","unstructured":"Soliman H, Theret M, Scott W, Hill L, Underhill TM, Hinz B, et al. Multipotent stromal cells: one name, multiple identities. Cell Stem Cell. 2021;28(10):1690\u2013707.","journal-title":"Cell Stem Cell"},{"issue":"8","key":"4535_CR43","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41581-018-0023-5","volume":"14","author":"Y Shi","year":"2018","unstructured":"Shi Y, Wang Y, Li Q, Liu K, Hou J, Shao C, et al. Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases. Nat Rev Nephrol. 2018;14(8):493\u2013507.","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"4535_CR44","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.jhep.2014.03.031","volume":"61","author":"LA Possamai","year":"2014","unstructured":"Possamai LA, Thursz MR, Wendon JA, Antoniades CG. Modulation of monocyte\/macrophage function: a therapeutic strategy in the treatment of acute liver failure. J Hepatol. 2014;61(2):439\u201345.","journal-title":"J Hepatol"},{"issue":"5","key":"4535_CR45","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1002\/lt.25049","volume":"24","author":"M Gazdic","year":"2018","unstructured":"Gazdic M, Markovic BS, Arsenijevic A, Jovicic N, Acovic A, Harrell CR, et al. Crosstalk between mesenchymal stem cells and T regulatory cells is crucially important for the Attenuation of acute liver injury. Liver Transpl. 2018;24(5):687\u2013702.","journal-title":"Liver Transpl"},{"issue":"8","key":"4535_CR46","doi-asserted-by":"publisher","first-page":"562","DOI":"10.21037\/atm.2020.02.119","volume":"8","author":"Y Cao","year":"2020","unstructured":"Cao Y, Ji C, Lu L. Mesenchymal stem cell therapy for liver fibrosis\/cirrhosis. Annals Translational Med. 2020;8(8):562.","journal-title":"Annals Translational Med"},{"issue":"1","key":"4535_CR47","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/s13287-022-03001-z","volume":"13","author":"L Yao","year":"2022","unstructured":"Yao L, Hu X, Dai K, Yuan M, Liu P, Zhang Q, et al. Mesenchymal stromal cells: promising treatment for liver cirrhosis. Stem Cell Res Ther. 2022;13(1):308.","journal-title":"Stem Cell Res Ther"},{"issue":"41","key":"4535_CR48","doi-asserted-by":"publisher","first-page":"2309697","DOI":"10.1002\/advs.202309697","volume":"11","author":"YC Lin","year":"2024","unstructured":"Lin YC, Chen MC, Huang SW, Chen Y, Ho JHC, Lin FY, et al. Targeting dual immune checkpoints PD-L1 and HLA\u2010G by trispecific T cell engager for treating heterogeneous lung cancer. Adv Sci. 2024;11(41):2309697.","journal-title":"Adv Sci"},{"key":"4535_CR49","unstructured":"Moayedfard Z, Lankarani KB, Alizadeh AA, Nekooeian AA, Dara M, Koohpeyma F, et al. The ameliorative effect of Adipose-Derived mesenchymal stem cells and their exosomes in Non-alcoholic steatohepatitis by simultaneously enhancing autophagic flux and suppressing Endoplasmic reticulum stress. Iranian Journal of Medical Sciences; 2025."},{"issue":"2","key":"4535_CR50","doi-asserted-by":"publisher","first-page":"80617","DOI":"10.21037\/apm-21-3286","volume":"11","author":"M Wang","year":"2022","unstructured":"Wang M, Zhang J, Gong N. Role of the PI3K\/Akt signaling pathway in liver ischemia reperfusion injury: A narrative review. Annals Palliat Med. 2022;11(2):80617\u2013817.","journal-title":"Annals Palliat Med"},{"key":"4535_CR51","doi-asserted-by":"publisher","first-page":"990","DOI":"10.3389\/fphys.2020.00990","volume":"11","author":"AL Wilkinson","year":"2020","unstructured":"Wilkinson AL, Qurashi M, Shetty S. The role of sinusoidal endothelial cells in the axis of inflammation and cancer within the liver. Front Physiol. 2020;11:990.","journal-title":"Front Physiol"},{"issue":"1","key":"4535_CR52","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1182\/blood-2002-12-3793","volume":"102","author":"Y-P Xia","year":"2003","unstructured":"Xia Y-P, Li B, Hylton D, Detmar M, Yancopoulos GD, Rudge JS. Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis. Blood. 2003;102(1):161\u20138.","journal-title":"Blood"},{"issue":"2","key":"4535_CR53","first-page":"747","volume":"77","author":"L Abdulazeem","year":"2022","unstructured":"Abdulazeem L, Tariq A, Abdalkareem Jasim S. An investigation of vascular endothelial growth factor (VEGFR-1 and VEGFR-2) in burn wound healing. Arch Razi Inst. 2022;77(2):747.","journal-title":"Arch Razi Inst"},{"key":"4535_CR54","doi-asserted-by":"publisher","first-page":"100958","DOI":"10.1016\/j.mtbio.2024.100958","volume":"25","author":"Q Shi","year":"2024","unstructured":"Shi Q, Xia Y, Wu M, Pan Y, Wu S, Lin J, et al. Mi-BMSCs alleviate inflammation and fibrosis in CCl4-and TAA-induced liver cirrhosis by inhibiting TGF-\u03b2\/Smad signaling. Mater Today Bio. 2024;25:100958.","journal-title":"Mater Today Bio"},{"issue":"1","key":"4535_CR55","first-page":"73","volume":"1","author":"Y Hashim","year":"2021","unstructured":"Hashim Y, Abdel Baky NA, Kamal MM, Gad A. Aliskiren and Fenofibrate constrict liver fibrosis by means of focusing on TGF-\u03b21\/Smad signaling pathway and actuating HGF expression. Azhar Int J Pharm Med Sci. 2021;1(1):73\u201386.","journal-title":"Azhar Int J Pharm Med Sci"},{"issue":"12","key":"4535_CR56","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.2174\/1389203718666171117103418","volume":"19","author":"J Krstic","year":"2018","unstructured":"Krstic J, Trivanovic D, Obradovic H, Kukolj T, Bugarski D, Santibanez JF. Regulation of mesenchymal stem cell differentiation by transforming growth factor beta superfamily. Curr Protein Pept Sci. 2018;19(12):1138\u201354.","journal-title":"Curr Protein Pept Sci"},{"key":"4535_CR57","doi-asserted-by":"crossref","unstructured":"Qin L, Liu N, Bao C- et al. Yang D-z, Ma G-x, Yi W-h,. Mesenchymal stem cells in fibrotic diseases\u2014the two sides of the same coin. Acta Pharmacologica Sinica. 2023;44(2):268\u2013\u200987.","DOI":"10.1038\/s41401-022-00952-0"},{"key":"4535_CR58","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.jconrel.2023.02.032","volume":"356","author":"J Zhang","year":"2023","unstructured":"Zhang J, Lu T, Xiao J, Du C, Chen H, Li R, et al. MSC-derived extracellular vesicles as nanotherapeutics for promoting aged liver regeneration. J Controlled Release. 2023;356:402\u201315.","journal-title":"J Controlled Release"},{"issue":"4","key":"4535_CR59","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1083\/jcb.201211138","volume":"200","author":"G Raposo","year":"2013","unstructured":"Raposo G, Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol. 2013;200(4):373\u201383.","journal-title":"J Cell Biol"},{"issue":"1","key":"4535_CR60","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s00109-022-02276-2","volume":"101","author":"Z Heydari","year":"2023","unstructured":"Heydari Z, Peshkova M, Gonen ZB, Coretchi I, Eken A, Yay AH, et al. EVs vs. EVs: MSCs and Tregs as a source of invisible possibilities. J Mol Med. 2023;101(1):51\u201363.","journal-title":"J Mol Med"},{"issue":"1","key":"4535_CR61","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/hep.31658","volume":"74","author":"X Hou","year":"2021","unstructured":"Hou X, Yin S, Ren R, Liu S, Yong L, Liu Y, et al. Myeloid-cell\u2013specific IL\u20106 signaling promotes MicroRNA\u2010223\u2010enriched exosome production to attenuate NAFLD\u2010associated fibrosis. Hepatology. 2021;74(1):116\u201332.","journal-title":"Hepatology"},{"key":"4535_CR62","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1007\/s12026-016-8798-6","volume":"64","author":"W Chen","year":"2016","unstructured":"Chen W, Huang Y, Han J, Yu L, Li Y, Lu Z, et al. Immunomodulatory effects of mesenchymal stromal cells-derived exosome. Immunol Res. 2016;64:831\u201340.","journal-title":"Immunol Res"},{"issue":"24","key":"4535_CR63","doi-asserted-by":"publisher","first-page":"9739","DOI":"10.3390\/ijms21249739","volume":"21","author":"GA Cabral-Pacheco","year":"2020","unstructured":"Cabral-Pacheco GA, Garza-Veloz I, Castruita-De la Rosa C, Ramirez-Acu\u00f1a JM, Perez-Romero BA, Guerrero-Rodriguez JF, et al. The roles of matrix metalloproteinases and their inhibitors in human diseases. Int J Mol Sci. 2020;21(24):9739.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"4535_CR64","doi-asserted-by":"publisher","first-page":"6596","DOI":"10.3390\/ijms22126596","volume":"22","author":"L Birtwistle","year":"2021","unstructured":"Birtwistle L, Chen X-M, Pollock C. Mesenchymal stem cell-derived extracellular vesicles to the rescue of renal injury. Int J Mol Sci. 2021;22(12):6596.","journal-title":"Int J Mol Sci"},{"key":"4535_CR65","first-page":"205","volume-title":"Hsp70: anti-apoptotic and tumorigenic protein","author":"A-L R\u00e9role","year":"2011","unstructured":"R\u00e9role A-L, Jego G, Garrido C. Hsp70: anti-apoptotic and tumorigenic protein. Molecular Chaperones: Methods and Protocols: Springer; 2011. pp. 205\u201330."},{"issue":"2","key":"4535_CR66","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1042\/BJ20100814","volume":"430","author":"DC Altieri","year":"2010","unstructured":"Altieri DC. Survivin and IAP proteins in cell-death mechanisms. Biochem J. 2010;430(2):199\u2013205.","journal-title":"Biochem J"},{"issue":"2","key":"4535_CR67","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3390\/pharmaceutics14020381","volume":"14","author":"R Alvites","year":"2022","unstructured":"Alvites R, Branquinho M, Sousa AC, Lopes B, Sousa P, Maur\u00edcio AC. Mesenchymal stem\/stromal cells and their paracrine activity\u2014immunomodulation mechanisms and how to influence the therapeutic potential. Pharmaceutics. 2022;14(2):381.","journal-title":"Pharmaceutics"},{"key":"4535_CR68","doi-asserted-by":"publisher","first-page":"120615","DOI":"10.1016\/j.lfs.2022.120615","volume":"301","author":"LA Faccioli","year":"2022","unstructured":"Faccioli LA, Dias ML, Paranhos BA, dos Santos Goldenberg RC. Liver cirrhosis: an overview of experimental models in rodents. Life Sci. 2022;301:120615.","journal-title":"Life Sci"},{"key":"4535_CR69","doi-asserted-by":"publisher","first-page":"1160053","DOI":"10.3389\/fmed.2023.1160053","volume":"10","author":"S Wu","year":"2023","unstructured":"Wu S, Wang X, Xing W, Li F, Liang M, Li K, et al. An update on animal models of liver fibrosis. Front Med. 2023;10:1160053.","journal-title":"Front Med"},{"issue":"5","key":"4535_CR70","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.bj.2020.04.011","volume":"44","author":"MR Khalil","year":"2021","unstructured":"Khalil MR, El-Demerdash RS, Elminshawy HH, Mehanna ET, Mesbah NM, Abo-Elmatty DM. Therapeutic effect of bone marrow mesenchymal stem cells in a rat model of carbon tetrachloride induced liver fibrosis. Biomedical J. 2021;44(5):598\u2013610.","journal-title":"Biomedical J"},{"key":"4535_CR71","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s13770-020-00274-4","volume":"17","author":"Y-H Kao","year":"2020","unstructured":"Kao Y-H, Lin Y-C, Lee P-H, Lin C-W, Chen P-H, Tai T-S, et al. Infusion of human mesenchymal stem cells improves regenerative niche in thioacetamide-injured mouse liver. Tissue Eng Regenerative Med. 2020;17:671\u201382.","journal-title":"Tissue Eng Regenerative Med"},{"issue":"1","key":"4535_CR72","first-page":"5485738","volume":"2020","author":"JH Jun","year":"2020","unstructured":"Jun JH, Kim JY, Choi JH, Lim J-Y, Kim K, Kim GJ. Exosomes from Placenta-Derived mesenchymal stem cells are involved in liver regeneration in hepatic failure induced by bile duct ligation. Stem Cells Int. 2020;2020(1):5485738.","journal-title":"Stem Cells Int"},{"issue":"1","key":"4535_CR73","first-page":"3662776","volume":"2021","author":"FC Schacher","year":"2021","unstructured":"Schacher FC, Martins Pezzi da Silva A, Silla LMR, Alvares-da-Silva MR. Bone marrow mesenchymal stem cells in Acute-on\u2010Chronic liver failure grades 2 and 3: A phase I\u2010II randomized clinical trial. Can J Gastroenterol Hepatol. 2021;2021(1):3662776.","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"20","key":"4535_CR74","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1089\/scd.2013.0500","volume":"23","author":"L Wang","year":"2014","unstructured":"Wang L, Han Q, Chen H, Wang K, Shan G-l, Kong F, et al. Allogeneic bone marrow mesenchymal stem cell transplantation in patients with UDCA-resistant primary biliary cirrhosis. Stem Cells Dev. 2014;23(20):2482\u20139.","journal-title":"Stem Cells Dev"},{"issue":"3","key":"4535_CR75","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.clinre.2017.11.003","volume":"42","author":"W Sang","year":"2018","unstructured":"Sang W, Lv B, Li K, Lu Y. Therapeutic efficacy and safety of umbilical cord mesenchymal stem cell transplantation for liver cirrhosis in Chinese population: a meta-analysis. Clin Res Hepatol Gastroenterol. 2018;42(3):193\u2013204.","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"10","key":"4535_CR76","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1097\/MEG.0000000000001455","volume":"31","author":"B Chen","year":"2019","unstructured":"Chen B, Pang L, Cao H, Wu D, Wang Y, Tao Y, et al. Autologous stem cell transplantation for patients with viral hepatitis-induced liver cirrhosis: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2019;31(10):1283\u201391.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"4535_CR77","first-page":"908275","volume":"2015","author":"X-R Ma","year":"2015","unstructured":"Ma X-R, Tang Y-L, Xuan M, Chang Z, Wang X-Y, Liang X-H. Transplantation of autologous mesenchymal stem cells for end-stage liver cirrhosis: a meta\u2010analysis based on seven controlled trials. Gastroenterol Res Pract. 2015;2015(1):908275.","journal-title":"Gastroenterol Res Pract"},{"key":"4535_CR78","doi-asserted-by":"publisher","first-page":"4789","DOI":"10.1007\/s11033-020-05428-0","volume":"47","author":"C Eder","year":"2020","unstructured":"Eder C, Schmidt-Bleek K, Geissler S, Sass FA, Maleitzke T, Pumberger M, et al. Mesenchymal stromal cell and bone marrow concentrate therapies for musculoskeletal indications: a concise review of current literature. Mol Biol Rep. 2020;47:4789\u2013814.","journal-title":"Mol Biol Rep"},{"issue":"1","key":"4535_CR79","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/s41392-022-01134-4","volume":"7","author":"DM Hoang","year":"2022","unstructured":"Hoang DM, Pham PT, Bach TQ, Ngo AT, Nguyen QT, Phan TT, et al. Stem cell-based therapy for human diseases. Signal Transduct Target Therapy. 2022;7(1):272.","journal-title":"Signal Transduct Target Therapy"},{"issue":"1","key":"4535_CR80","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/jcmm.14788","volume":"24","author":"C Hu","year":"2020","unstructured":"Hu C, Wu Z, Li L. Pre-treatments enhance the therapeutic effects of mesenchymal stem cells in liver diseases. J Cell Mol Med. 2020;24(1):40\u20139.","journal-title":"J Cell Mol Med"},{"key":"4535_CR81","doi-asserted-by":"publisher","first-page":"1400347","DOI":"10.3389\/fcell.2024.1400347","volume":"12","author":"AB \u010cesnik","year":"2024","unstructured":"\u010cesnik AB, \u0160vajger U. The issue of heterogeneity of MSC-based advanced therapy medicinal products\u2013a review. Front Cell Dev Biology. 2024;12:1400347.","journal-title":"Front Cell Dev Biology"},{"issue":"1","key":"4535_CR82","first-page":"9589600","volume":"2022","author":"K Shah","year":"2022","unstructured":"Shah K, Shah N, Ghassemi F, Ly C, George T, Lutz C, et al. Alloreactivity of allogeneic mesenchymal stem\/stromal cells and other cellular therapies: a concise review. Stem Cells Int. 2022;2022(1):9589600.","journal-title":"Stem Cells Int"},{"issue":"12","key":"4535_CR83","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1038\/s41419-018-1239-9","volume":"9","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Li R, Rong W, Han M, Cui C, Feng Z, et al. Therapeutic effect of hepatocyte growth factor-overexpressing bone marrow-derived mesenchymal stem cells on CCl4-induced hepatocirrhosis. Cell Death Dis. 2018;9(12):1186.","journal-title":"Cell Death Dis"},{"issue":"11","key":"4535_CR84","doi-asserted-by":"publisher","first-page":"2802","DOI":"10.15419\/bmrat.v5i11.498","volume":"5","author":"A Putra","year":"2018","unstructured":"Putra A, Antari AD, Kustiyah AR, Intan YSN, Sadyah NAC, Wirawan N, et al. Mesenchymal stem cells accelerate liver regeneration in acute liver failure animal model. Biomedical Res Therapy. 2018;5(11):2802\u201310.","journal-title":"Biomedical Res Therapy"},{"issue":"1","key":"4535_CR85","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/01.TP.0000128326.95294.14","volume":"78","author":"B Fang","year":"2004","unstructured":"Fang B, Shi M, Liao L, Yang S, Liu Y, Zhao RC. Systemic infusion of FLK1\u2009+\u2009mesenchymal stem cells ameliorate carbon tetrachloride-induced liver fibrosis in mice. Transplantation. 2004;78(1):83\u20138.","journal-title":"Transplantation"},{"issue":"46","key":"4535_CR86","doi-asserted-by":"publisher","first-page":"8152","DOI":"10.3748\/wjg.v23.i46.8152","volume":"23","author":"G-Z Zhang","year":"2017","unstructured":"Zhang G-Z, Sun H-C, Zheng L-B, Guo J-B, Zhang X-L. In vivo hepatic differentiation potential of human umbilical cord-derived mesenchymal stem cells: therapeutic effect on liver fibrosis\/cirrhosis. World J Gastroenterol. 2017;23(46):8152.","journal-title":"World J Gastroenterol"},{"key":"4535_CR87","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12876-014-0198-6","volume":"14","author":"YO Jang","year":"2014","unstructured":"Jang YO, Kim MY, Cho MY, Baik SK, Cho YZ, Kwon SO. Effect of bone marrow-derived mesenchymal stem cells on hepatic fibrosis in a thioacetamide-induced cirrhotic rat model. BMC Gastroenterol. 2014;14:1\u201312.","journal-title":"BMC Gastroenterol"},{"issue":"7","key":"4535_CR88","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1002\/hep4.1071","volume":"1","author":"T Matsuda","year":"2017","unstructured":"Matsuda T, Takami T, Sasaki R, Nishimura T, Aibe Y, Paredes BD, et al. A canine liver fibrosis model to develop a therapy for liver cirrhosis using cultured bone marrow\u2013derived cells. Hepatol Commun. 2017;1(7):691\u2013703.","journal-title":"Hepatol Commun"},{"issue":"1","key":"4535_CR89","doi-asserted-by":"publisher","first-page":"e0210588","DOI":"10.1371\/journal.pone.0210588","volume":"14","author":"T Nishimura","year":"2019","unstructured":"Nishimura T, Takami T, Sasaki R, Aibe Y, Matsuda T, Fujisawa K, et al. Liver regeneration therapy through the hepatic artery-infusion of cultured bone marrow cells in a canine liver fibrosis model. PLoS ONE. 2019;14(1):e0210588.","journal-title":"PLoS ONE"},{"issue":"4","key":"4535_CR90","doi-asserted-by":"publisher","first-page":"e13115","DOI":"10.1590\/1678-4162-13115","volume":"76","author":"L Santos","year":"2024","unstructured":"Santos L, Viana A, Bernasconi N, Basso P, Krause A. Improvement of clinical and laboratory parameters in a canine with idiopathic chronic hepatitis after transplantation of allogeneic mesenchymal cells derived from bone marrow-case report. Arquivo Brasileiro De Med Veterin\u00e1ria E Zootecnia. 2024;76(4):e13115.","journal-title":"Arquivo Brasileiro De Med Veterin\u00e1ria E Zootecnia"},{"key":"4535_CR91","doi-asserted-by":"crossref","unstructured":"Skuratov AG, Osipov BB, Lyzikov AN, Zinovkin DA, Adam IM, Kaplan ML et al. Use of mesenchymal stem cell transplantation as a treatment for liver cirrhosis in animal models. Cureus. 2024;16(10).","DOI":"10.7759\/cureus.71720"},{"issue":"1","key":"4535_CR92","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13287-022-02734-1","volume":"13","author":"Y Yang","year":"2022","unstructured":"Yang Y, Chen Y, Zhao Y, Ji F, Zhang L, Tang S, et al. Human menstrual blood-derived stem cell transplantation suppresses liver injury in DDC-induced chronic cholestasis. Stem Cell Res Ther. 2022;13(1):57.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"4535_CR93","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0254-6272(15)30010-8","volume":"35","author":"Y Lihua","year":"2015","unstructured":"Lihua Y, Yun W, Xiaohua W, Yanqing L. Effect of allogeneic umbilical cord mesenchymal stem cell transplantation in a rat model of hepatic cirrhosis. J Tradit Chin Med. 2015;35(1):63\u20138.","journal-title":"J Tradit Chin Med"}],"container-title":["Stem Cell Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04535-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-025-04535-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04535-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T14:57:21Z","timestamp":1757343441000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-025-04535-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,5]]},"references-count":93,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4535"],"URL":"https:\/\/doi.org\/10.1186\/s13287-025-04535-8","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,5]]},"assertion":[{"value":"19 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"We have no restrictions for publishing this review.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"421"}}